Cancer treatments, despite their transformative potential, often come with unintended cardiovascular risks. Cardio-oncology focuses on understanding and mitigating these risks through a combination of cutting-edge diagnostics and personalized care. By using technologies like cardiac MRI and strain imaging, clinicians can detect early signs of heart stress caused by therapies such as radiation or targeted treatments. This collaborative field not only emphasizes prevention but also explores innovative therapeutics to repair heart damage. As survival rates improve, the integration of cardio-oncology ensures long-term health, enabling patients to overcome cancer without compromising cardiovascular wellness.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States